Hazel Senz was diagnosed with Stage IV lung cancer in March of 2014. She has been on a series of medications, including targeted therapy for her ALK mutation. She talks about her experience with research and clinical trials below.
Hazel Senz was diagnosed with Stage IV lung cancer in March of 2014. She has been on a series of medications, including targeted therapy for her ALK mutation. She talks about her experience with research and clinical trials below.
Here